Purchase Order 75N93021P01438
Award Date 9/16/21
Potential Completion Date 9/16/22
Potential Value $47K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Jose, CA 95131, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $25,072.00 firm fixed price purchase order contract to Becton, Dickinson And Company (BD) for BD reagents to support vaccine research. The contract does not have a set-aside designation and is scheduled for completion on February 24, 2023. BD is a global medical technology company that provides instruments, reagents, and services for biomedical research and...
- This firm-fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) for $24,138.00. The contract is for the delivery of unspecified products or services related to BD's Biosciences division, which provides instruments, reagents, and services that support biomedical research and clinical applications through flow cytometry, cell imaging, and genomics...
- This federal contract award is for $110,508.75 and was issued by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases to Becton, Dickinson and Company (BD) for the supply of BD Biosciences Immunocytometry products. The contract is a firm fixed-price Purchase Order with a completion date of September 30, 2017. BD, a leading global medical technology company, manufactures and supplies a range of medical devices,...
- This federal contract was awarded by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases to Becton, Dickinson and Company (BD) for COVID-19 research. The $132,747.71 firm-fixed-price purchase order is for BD reagents to support mission-critical COVID-19 pre- and post-vaccine studies. The contract has no set-aside designation. BD is a global medical technology manufacturer that provides a wide range of products and...
- The National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), awarded a $54,930.70 firm fixed-price purchase order to Becton, Dickinson and Company (BD) for the procurement of 64 specific BD Biosciences brand conjugated antibodies and laboratory reagents. The contract, which has no set-aside designation, was issued through a Request for Quotes (RFQ-NIAID-25-2258428) under the Simplified Acquisition Procedures of the Federal Acquisition...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) for $33,675.60. The contract is for BD Biosciences, a division of BD, to provide biomedical instruments, reagents, and services that support flow cytometry, cell imaging, and genomics technologies. BD has extensive experience providing specialized equipment and consumables to support...
- Becton, Dickinson and Company, doing business as BD, has been awarded a $20,504.50 firm fixed price purchase order contract by the Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide BD Biosciences reagents. The place of performance will be BD's facility in Franklin Lakes, New Jersey. The contract period of performance spans from September 14, 2023 through December 29, 2023. No major subcontractors or set aside...
- This is a $68,497.20 firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Becton, Dickinson And Company (BD) for the delivery of biological reagents. The contract has a period of performance through July 31, 2025. BD is a global medical technology company that has received numerous federal contract and subcontract awards to provide specialized equipment, consumables, and services in support of biomedical...
- The National Institute of Allergy and Infectious Diseases awarded a purchase order to Becton, Dickinson and Company (BD Biosciences) on June 23, 2021, for flow cytometry antibodies with a ceiling value of $16,700.58. This firm fixed-price contract represents a de-obligation action intended to administratively expend unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a) in preparation for the September 30, 2026 closing of the period of availability for...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases (NIAID) awarded Becton, Dickinson And Company (BD), a manufacturer of medical devices and supplies, a firm fixed-price purchase order valued at $20,116.80 for high parameter custom conjugates. This award does not have a set-aside designation. The award has a completion date of August 15, 2024. BD is a prime contractor that has received numerous federal contract awards...